At AACR17 one of the fascinating topics that came up in several presentations was exosomes, what they are, and how the information they contain can be used to best effect.
At #AACR17 Dan Haber says plasma, CTCs, exosomes together help predict pts at high risk for cancer progression
— Rosandra Kaplan (@rosiekaplanmd) April 4, 2017
One of the evangelists of exosomes, and their potential in cancer research is Theresa Whiteside, PhD who is a Professor of Pathology, Immunology and Otolaryngology at the University of Pittsburgh.
At the recent 2017 American Association for Cancer Research (AACR) annual meeting, Dr Whiteside gave two fascinating talks in education symposia. Afterwards, she kindly spoke to BSB about her research.
Love them or hate them, exosomes were a hot topic in Washington DC and something you should be aware of, if you aren’t already.
— Emil Lou, MD, PhD (@cancerassassin1) April 4, 2017
This post continues our volley of expert interviews from AACR17 and is the ninth in the series.